International Neuroblastoma Risk Group Task Force (INRG)
3 June 2014
The INRG Executive reviews all applications.
Once an application is approved, the INRG Executive Committee will identify investigators from different regions of the world with expertise in the research focus of the application and forward these names to the principal investigator of the proposal as possible collaborators. It is anticipated that collaboration with international experts will greatly enhance the research conducted with these data.
Authorship will be determined by the primary investigators.
Co-authorship may be warranted for collaborators who actively participate in the analysis of the data and the writing of the final manuscript.
The recipient of the data agrees to include the following acknowledgment in all publications that include data from the INRG database:
The INRG database is supported in part by the William Guy Forbeck Research Foundation, the St. Baldrick’s Foundation, the Little Heroes Cancer Research Fund, Children’s Neuroblastoma Cancer Foundation, Neuroblastoma Children’s Cancer Foundation, the Super Jake Foundation, the Alex’s Lemonade Stand Foundation, and The Matthew Bittker Foundation. Data included in the INRG database were provided by Children’s Oncology Group [COG], Pediatric Oncology Group [POG], Children’s Cancer Study Group [CCSG], German Gesellschaft für Pädiatrische Onkologie und Hämatologie [GPOH], European Neuroblastoma Study Group [ENSG], International Society of Paediatric Oncology Europe Neuroblastoma Group [SIOPEN], Japanese Neuroblastoma Study Group [JNBSG], Japanese Infantile Neuroblastoma Co-operative Study Group [JINCS], Spanish Neuroblastoma Group and the Italian Neuroblastoma Group.
The INRG Executive Committee will review all papers prior to submission for publication to ensure proper acknowledgments are included.